U.S. Fed decision on Wednesday Tilray gains on upbeat Q4...

	  U.S. Fed decision on Wednesday 

	  Tilray gains on upbeat Q4 revenue 

	  TSX up 0.4% 

(Updated at 10:15 a.m. ET)

Canada's main stock index hit a two-week high on Tuesday, led by gains in healthcare shares, while investors await a raft of corporate earnings and the U.S. Federal Reserve's rate decision to gauge the outlook for global monetary policy.

At 10:15 a.m. ET (1415 GMT), the Toronto Stock Exchange's S&P/TSX composite index .GSPTSE was up 89.94 points, or 0.39%, at 22869.51.

Shares of cannabis firm Tilray Brands TLRY.TO TLRY.O jumped 14.4% to over two-month highs after reporting upbeat fourth-quarter revenue and a smaller-than-expected loss, powering healthcare shares .GSPTTHC 3.8% higher.

All heavyweight sectors on the TSX were trading in the green, with rate-sensitive financial shares .SPTTFS up 0.5%.

Energy shares .SPTTEN also advanced 0.5% despite oil prices drifting lower.

Gold prices rose, boosting the materials sector .GSPTTMT , as investors awaited the Fed's commentary on its monetary policy and a deluge of U.S. economic data due later in the week for more clues on the pace and scale of the U.S. central bank's interest rate cuts.

All eyes will be on the Fed on Wednesday for their decision, where markets expect the central bank to keep the interest rates unchanged while providing commentary to set the base for a September rate cut. 0#FEDWATCH

"The Fed is playing a balancing act: perfectly time rate cuts to cultivate a soft landing without reigniting inflation pressures," said Seema Shah, chief global strategist at Principal Asset Management.

Wall Street peers climbed as cautious investors awaited the day's Big Tech earnings and labor market data, hoping for clues on the timing of interest-rate cuts in this week's U.S. policy decision.

Shares of Filo Corp FIL.TO surged 9.3% after global miner BHP Group (BHP) and Canada-listed Lundin Mining LUN.TO decided to jointly take over the developer for C$4.5 billion ($3.25 billion).

Bank of Montreal BMO.TO slid 4.0% after RBC cut its rating on the stock to "sector perform" and also lower the target price to C$118 from C$124.